Cara Therapeutics: 200% Upside Possible With FDA Approval
magicmine/iStock via Getty Images
Thesis
Cara Therapeutics (CARA) has an important upcoming PDUFA date, potentially yielding the first approved drug in the company’s history, and therefore a new and consistent cash flow. KORSUVA IV approval would allow…
